A retrospective study of SARS-CoV-2 vaccine response in patients treated for haematological B-cell malignancy and rheumatological disease
Latest Information Update: 20 Apr 2022
At a glance
- Drugs AZD 1222 (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
Most Recent Events
- 20 Apr 2022 New trial record